Related by context. Frequent words. (Click for all words.) 82 Phase IIb 82 Phase 2a 81 Phase 2a clinical 80 Phase IIa clinical 80 Phase IIa trial 80 Phase Ib 79 Phase 2b study 78 Phase 1b 78 Phase IIb clinical 78 Phase IIb trial 77 Phase III clinical 76 Phase III 76 Phase 2b trial 75 Phase 2b 74 Phase 2b clinical 73 pivotal Phase III 72 Phase II 71 Phase III clinical trials 70 clinical trial 69 Phase III trials 69 double blind placebo 68 dose escalation study 68 PRX # 68 pivotal Phase 68 placebo controlled 66 preclinical 66 pharmacokinetic 65 ISIS # 65 preclinical studies 64 tolerability 63 randomized Phase 63 ADX# 63 safety tolerability 63 RDEA# 63 Phase 63 clinical trials 62 initiate Phase 62 IND enabling 62 dose escalation 62 randomized placebo controlled 62 multicenter 62 investigational compound 62 oral formulation 62 randomized double 61 INCB# [002] 61 blind randomized placebo 61 randomized controlled 61 investigational drug 61 LEVADEX 61 IMGN# 60 mipomersen 60 laquinimod 60 pharmacokinetics 60 ALKS 59 carfilzomib 59 Marqibo 59 pharmacodynamic 59 investigational 59 randomized clinical 59 CRx 59 MGCD# [001] 58 Locteron 58 unblinded 58 pharmacodynamics 58 eculizumab 58 perifosine 58 Bronchitol 58 AP# [003] 58 ARRY 58 ofatumumab 58 pharmacokinetic profile 58 RG# [001] 58 Clinical Trial 58 CYT# 58 IDX# 58 Preclinical 58 prospective randomized 58 XL# [003] 58 blind randomized 58 Clinical Study 58 AEZS 58 Opexa 58 LymphoStat B 57 New Drug IND 57 Investigational 57 Marketing Authorization Application 57 daclizumab 57 Santhera 57 ASA# 57 oral dosing 57 voreloxin 57 ACTEMRA 56 blind placebo controlled 56 tolerability profile 56 NKTR 56 Marketing Authorization Application MAA 56 Preclinical studies 56 relapsing remitting multiple sclerosis 56 linaclotide 56 NDA submission 56 efficacy